Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:21 pm Purchase | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ARMISTICE CAPITAL LLC | 4,626,190 9.99% | 1,629,079 (+54.35%) | View |
| 2024-02-13 8:02 pm Sale | 13G | ARIDIS PHARMACEUTICALS INC ARDS | Lind Global Fund II LP | 0 0% | -3,000,000 (Position Closed) | View |
| 2023-03-20 4:35 pm Purchase | 13G | ARIDIS PHARMACEUTICALS INC ARDS | Lind Global Fund II LP | 3,000,000 8.3% | 3,000,000 (New Position) | View |
| 2023-02-14 12:00 pm Unchanged | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ARMISTICE CAPITAL LLC | 2,997,111 9.99% | 0 (Unchanged) | View |
| 2023-02-10 10:25 am Unchanged | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ASTRAZENECA PLC AZN | 884,956 3.4% | 0 (Unchanged) | View |
| 2022-12-19 06:05 am Purchase | 13G | ARIDIS PHARMACEUTICALS INC ARDS | Cystic Fibrosis Foundation | 5,168,732 19.9% | 5,168,732 (New Position) | View |
| 2022-02-14 2:09 pm Sale | 13G | ARIDIS PHARMACEUTICALS INC ARDS | Francis Capital Management LLC | 142,838 1% | -534,021 (-78.90%) | View |
| 2021-07-27 1:20 pm Purchase | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ASTRAZENECA PLC AZN | 884,956 7.3% | 884,956 (New Position) | View |
| 2021-04-01 4:50 pm Purchase | 13G | ARIDIS PHARMACEUTICALS INC ARDS | Francis Capital Management LLC | 676,859 6.1% | 676,859 (New Position) | View |